169 related articles for article (PubMed ID: 14657952)
1. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.
Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
Mod Pathol; 2004 Feb; 17(2):180-8. PubMed ID: 14657952
[TBL] [Abstract][Full Text] [Related]
2. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
4. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC
Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms.
Lechpammer M; Resnick MB; Sabo E; Yakirevich E; Greaves WO; Sciandra KT; Tavares R; Noble LC; DeLellis RA; Wang LJ
Mod Pathol; 2008 Nov; 21(11):1320-9. PubMed ID: 18587324
[TBL] [Abstract][Full Text] [Related]
6. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.
Leroy X; Zerimech F; Zini L; Copin MC; Buisine MP; Gosselin B; Aubert JP; Porchet N
Am J Clin Pathol; 2002 Jul; 118(1):47-51. PubMed ID: 12109855
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
10. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.
Rausch S; Beermann J; Scharpf M; Hennenlotter J; Fend F; Stenzl A; Schollenberger D; Bedke J; Kruck S
World J Urol; 2016 Dec; 34(12):1635-1641. PubMed ID: 26995391
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of morphologic subdivision of papillary renal cell carcinoma and MUC1 expression].
Blel A; Kourda N; Baltagi Ben Jilani S; Zermani R
Prog Urol; 2008 Oct; 18(9):575-9. PubMed ID: 18986629
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
14. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
15. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
16. Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas.
Cioca A; Muntean D; Bungardean C; Raica M; Cimpean AM
Anticancer Res; 2018 Jan; 38(1):259-263. PubMed ID: 29277781
[TBL] [Abstract][Full Text] [Related]
17. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of EMA expression in the renal parenchyma tumors.
Alexa A; Baderca F; Lighezan R; Zăhoi DE; Izvernariu D
Rom J Morphol Embryol; 2011; 52(3 Suppl):1019-25. PubMed ID: 22119819
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression profiles of MUC1 and MUC2 mucins in urothelial tumors of bladder.
Gonul II; Cakir A; Sozen S
Indian J Pathol Microbiol; 2018; 61(3):350-355. PubMed ID: 30004053
[TBL] [Abstract][Full Text] [Related]
20. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
